Protein Engineering
, Protein Structure Elucidation Methods: Pros, Restrictions, and Examples
Method Proteins Suitable Restrictions Examples
X-ray - Proteins that can - Requires crystallization, - Myoglobin (first
Crystallography form well-ordered which is difficult for solved protein).
crystals. flexible, disordered, or - Hemoglobin.
- Large proteins and membrane proteins. - Enzyme
complexes (with - Cannot study protein complexes.
sufficient dynamics.
crystallization). - Artifacts from crystal
packing.
NMR - Small to - Limited to small proteins - Ubiquitin
Spectroscopy medium-sized proteins due to overlap of signals (dynamic
(≤ 30 kDa). for larger ones. structure).
- Flexible and dynamic - Requires high sample - Small peptides.
proteins. purity and solubility. - Protein-ligand
- Protein-protein or - Time-consuming. complexes.
protein-ligand
interactions.
Computational - Proteins with known - Dependent on - SARS-CoV-2
Methods homologs for availability of known spike protein
homology modeling. templates (for homology (AlphaFold
- Any protein for de modeling). prediction).
novo predictions with - De novo predictions are - Drug target
limited accuracy. less reliable for complex or proteins modeled
large proteins. for drug discovery.
- Computational
resource-intensive.
Key Takeaways:
1. X-ray Crystallography: Gold standard for high-resolution structures but unsuitable for
disordered proteins or those resistant to crystallization.
2. NMR Spectroscopy: Ideal for studying protein dynamics and interactions in solution but
limited to smaller proteins.
3. Computational Methods: Fast and cost-effective, with expanding utility (e.g.,
AlphaFold), but still requires experimental validation for novel predictions.
,Reasons Why Some Proteins Remain Structurally Undetermined
1. Difficulties in Crystallization (X-ray Crystallography)
● Many proteins, especially membrane proteins and intrinsically disordered proteins
(IDPs), are hard to crystallize due to their flexibility or hydrophobicity.
● Some proteins exist in multiple conformations, preventing the formation of well-ordered
crystals.
● Crystallization is time-consuming, often requiring trial and error.
Example: Many G-protein-coupled receptors (GPCRs) remained undetermined for years due to
their resistance to crystallization.
2. Size and Complexity (NMR Spectroscopy)
● Large proteins or complexes (>30 kDa) produce complex overlapping signals, making it
difficult to analyze their structure using NMR.
● Proteins with multiple subunits or those that interact with other biomolecules pose
additional challenges.
Example: Multi-protein complexes like the ribosome are too large for conventional NMR.
3. Instability or Aggregation
● Some proteins are inherently unstable outside their native environment and degrade or
denature during purification.
● Proteins prone to aggregation (e.g., amyloid-forming proteins) are difficult to isolate in a
form suitable for structural studies.
Example: Amyloid beta peptides, associated with Alzheimer's disease, are challenging to study
structurally due to their aggregation tendency.
4. Membrane Proteins
● Membrane proteins are embedded in lipid bilayers, making them hydrophobic and
difficult to extract and purify in a functional state.
● Mimicking their natural environment in vitro is technically demanding.
, Example: Ion channels and transporters, like aquaporins, took years to resolve due to these
difficulties.
5. Dynamic and Flexible Nature (IDPs)
● Intrinsically disordered proteins lack a fixed 3D structure, existing instead as ensembles
of conformations.
● Such proteins are unsuitable for X-ray crystallography or traditional NMR, though
computational and advanced NMR methods are evolving to address this.
Example: Alpha-synuclein, involved in Parkinson’s disease, is an IDP.
6. Lack of Computational Homologs or Templates
● For computational methods like homology modeling, the lack of a similar protein
structure in databases hinders accurate prediction.
● Proteins from rare organisms or with unique functions often lack homologs.
Example: Novel viral proteins without known analogs in structural databases.
7. Resource and Time Constraints
● Structural determination is expensive, requiring access to advanced facilities (e.g.,
synchrotrons for X-ray crystallography).
● Many proteins are not prioritized for study due to limited funding or their perceived lack
of immediate biological importance.
Example: Proteins from understudied organisms or orphan diseases.
Advances Aiding Structural Determination
1. Cryo-Electron Microscopy (Cryo-EM): Revolutionizing the study of large complexes and
membrane proteins without requiring crystallization.
2. AlphaFold: Predicts protein structures computationally with remarkable accuracy,
though experimental validation is often still necessary.
, Protein Structure Elucidation Methods: Pros, Restrictions, and Examples
Method Proteins Suitable Restrictions Examples
X-ray - Proteins that can - Requires crystallization, - Myoglobin (first
Crystallography form well-ordered which is difficult for solved protein).
crystals. flexible, disordered, or - Hemoglobin.
- Large proteins and membrane proteins. - Enzyme
complexes (with - Cannot study protein complexes.
sufficient dynamics.
crystallization). - Artifacts from crystal
packing.
NMR - Small to - Limited to small proteins - Ubiquitin
Spectroscopy medium-sized proteins due to overlap of signals (dynamic
(≤ 30 kDa). for larger ones. structure).
- Flexible and dynamic - Requires high sample - Small peptides.
proteins. purity and solubility. - Protein-ligand
- Protein-protein or - Time-consuming. complexes.
protein-ligand
interactions.
Computational - Proteins with known - Dependent on - SARS-CoV-2
Methods homologs for availability of known spike protein
homology modeling. templates (for homology (AlphaFold
- Any protein for de modeling). prediction).
novo predictions with - De novo predictions are - Drug target
limited accuracy. less reliable for complex or proteins modeled
large proteins. for drug discovery.
- Computational
resource-intensive.
Key Takeaways:
1. X-ray Crystallography: Gold standard for high-resolution structures but unsuitable for
disordered proteins or those resistant to crystallization.
2. NMR Spectroscopy: Ideal for studying protein dynamics and interactions in solution but
limited to smaller proteins.
3. Computational Methods: Fast and cost-effective, with expanding utility (e.g.,
AlphaFold), but still requires experimental validation for novel predictions.
,Reasons Why Some Proteins Remain Structurally Undetermined
1. Difficulties in Crystallization (X-ray Crystallography)
● Many proteins, especially membrane proteins and intrinsically disordered proteins
(IDPs), are hard to crystallize due to their flexibility or hydrophobicity.
● Some proteins exist in multiple conformations, preventing the formation of well-ordered
crystals.
● Crystallization is time-consuming, often requiring trial and error.
Example: Many G-protein-coupled receptors (GPCRs) remained undetermined for years due to
their resistance to crystallization.
2. Size and Complexity (NMR Spectroscopy)
● Large proteins or complexes (>30 kDa) produce complex overlapping signals, making it
difficult to analyze their structure using NMR.
● Proteins with multiple subunits or those that interact with other biomolecules pose
additional challenges.
Example: Multi-protein complexes like the ribosome are too large for conventional NMR.
3. Instability or Aggregation
● Some proteins are inherently unstable outside their native environment and degrade or
denature during purification.
● Proteins prone to aggregation (e.g., amyloid-forming proteins) are difficult to isolate in a
form suitable for structural studies.
Example: Amyloid beta peptides, associated with Alzheimer's disease, are challenging to study
structurally due to their aggregation tendency.
4. Membrane Proteins
● Membrane proteins are embedded in lipid bilayers, making them hydrophobic and
difficult to extract and purify in a functional state.
● Mimicking their natural environment in vitro is technically demanding.
, Example: Ion channels and transporters, like aquaporins, took years to resolve due to these
difficulties.
5. Dynamic and Flexible Nature (IDPs)
● Intrinsically disordered proteins lack a fixed 3D structure, existing instead as ensembles
of conformations.
● Such proteins are unsuitable for X-ray crystallography or traditional NMR, though
computational and advanced NMR methods are evolving to address this.
Example: Alpha-synuclein, involved in Parkinson’s disease, is an IDP.
6. Lack of Computational Homologs or Templates
● For computational methods like homology modeling, the lack of a similar protein
structure in databases hinders accurate prediction.
● Proteins from rare organisms or with unique functions often lack homologs.
Example: Novel viral proteins without known analogs in structural databases.
7. Resource and Time Constraints
● Structural determination is expensive, requiring access to advanced facilities (e.g.,
synchrotrons for X-ray crystallography).
● Many proteins are not prioritized for study due to limited funding or their perceived lack
of immediate biological importance.
Example: Proteins from understudied organisms or orphan diseases.
Advances Aiding Structural Determination
1. Cryo-Electron Microscopy (Cryo-EM): Revolutionizing the study of large complexes and
membrane proteins without requiring crystallization.
2. AlphaFold: Predicts protein structures computationally with remarkable accuracy,
though experimental validation is often still necessary.
